BioRem Inc.
Toronto Stock Exchange VenturesTotal Valuation
BioRem Inc. carries a market capitalization of 49.95M, placing it among publicly traded companies globally. Its enterprise value stands at 32.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 49.95M |
| Enterprise Value | 32.69M |
Share Statistics
BioRem Inc. currently has 16.13M shares outstanding.
| Shares Outstanding | 16.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
BioRem Inc. trades at a trailing price-to-earnings ratio of 13.00. The price-to-sales ratio is 0.90, and the price-to-book ratio stands at 3.55.
| PE Ratio | 13.00 |
| PS Ratio | 0.90 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | 19.28 |
| P/OCF Ratio | 22.06 |
Enterprise Valuation
On an enterprise value basis, BioRem Inc. trades at an EV/EBITDA multiple of 4.59 and an EV/FCF ratio of 13.18. The EV/Sales ratio of 0.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.74 |
| EV / EBITDA | 4.59 |
| EV / EBIT | 4.89 |
| EV / FCF | 13.18 |
Financial Position
BioRem Inc. maintains a current ratio of 2.02, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.32, indicating elevated leverage, while an interest coverage ratio of 46.22 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.02 |
| Quick Ratio | 1.55 |
| Debt / Equity | 17.32 |
| Debt / EBITDA | 0.37 |
| Interest Coverage | 46.22 |
Financial Efficiency
BioRem Inc. posts a return on equity of 34.94 and a return on invested capital of 30.06.
| Return on Equity (ROE) | 34.94 |
| Return on Assets (ROA) | 10.31 |
| Return on Invested Capital (ROIC) | 30.06 |
| Return on Capital Employed (ROCE) | 27.03 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.14 |
Taxes
Over the trailing twelve months, BioRem Inc. has paid 1.57M in income taxes, reflecting an effective tax rate of 23.96.
| Income Tax | 1.57M |
| Effective Tax Rate | 23.96 |
Stock Price Statistics
BioRem Inc.'s stock has gained approximately 31.06383% over the past 52 weeks. The 50-day moving average sits at 3.19, while the 200-day moving average is 2.60.
| Beta (5Y) | N/A |
| 52-Week Price Change | 31.06383% |
| 50-Day Moving Average | 3.19 |
| 200-Day Moving Average | 2.60 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, BioRem Inc. generated 44.44M in revenue and converted that into 3.08M in net income, yielding earnings per share of 0.27. EBITDA reached 7.11M, while operating income came in at 6.69M.
| Revenue | 44.44M |
| Gross Profit | 13.05M |
| Operating Income | 6.69M |
| Pretax Income | 6.55M |
| Net Income | 3.08M |
| EBITDA | 7.11M |
| EBIT | 6.69M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
BioRem Inc. holds 9.99M in cash and equivalents against 2.65M in total debt, resulting in a net debt position of -8.28M. Total book value stands at 11.26M, with working capital of 14.51M providing operational flexibility.
| Cash & Cash Equivalents | 9.99M |
| Total Debt | 2.65M |
| Net Debt | -8.28M |
| Equity (Book Value) | 11.26M |
| Book Value Per Share | 0.69 |
| Working Capital | 14.51M |
Cash Flow
BioRem Inc. produced 1.81M in operating cash flow over the past twelve months. After subtracting -548,337.00 in capital expenditures, free cash flow totaled 1.27M - equivalent to 0.08 per share.
| Operating Cash Flow | 1.81M |
| Capital Expenditures | -548,337.00 |
| Free Cash Flow | 1.27M |
| FCF Per Share | 0.08 |
Margins
BioRem Inc. operates with a gross margin of 29.36, reflecting its pricing power and cost economics. The operating margin of 15.05 and net profit margin of 6.93 provide insight into operational efficiency.
| Gross Margin | 29.36 |
| Operating Margin | 15.05 |
| Pretax Margin | 14.74 |
| Profit Margin | 6.93 |
| EBITDA Margin | 16.01 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.86 |
| FCF Yield | 5.19 |
Stock Splits
BioRem Inc.'s most recent stock split took place on January 21, 2005 with a 4:1 split ratio.
| Last Split Date | 1/21/2005 |
| Split Ratio | 4:1 |
Scores
BioRem Inc. posts an Altman Z-Score of 4.41, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.41 |